ConcertAI subsidiary TeraRecon has formed a strategic partnership with U.K.-based AI software developer Optellum.
Under the agreement, TeraRecon will integrate Optellum's Virtual Nodule Clinic application into its Eureka Clinical AI platform. Virtual Nodule Clinic is an AI app for early lung cancer diagnosis based on CT scans and includes a validated lung cancer prediction score that may be useful in the characterization of pulmonary nodules, TeraRecon added.
